INS and hypertriglyceridemia: Insulin therapy is routinely used to specifically treat hypertriglyceridaemia (HTG)-induced pancreatitis45,46, characterised by plasma lipids exceeding 1,000 mg/dL (normal range, 101–150 mg/dL).